IVEMEND 150mg 1mg / ml powder infusion solution medication leaflet

A04AD12 fosaprepitant • Alimentary tract and metabolism | Antiemetics and antinauseants | Other antiemetics

Fosaprepitant is a medication used to prevent nausea and vomiting caused by cancer chemotherapy. It belongs to the class of neurokinin-1 (NK1) receptor antagonists and works by blocking signals in the brain that trigger the sensation of nausea.

Fosaprepitant is administered intravenously, usually before the start of chemotherapy, as part of a protocol combined with other antiemetic drugs. The dose is determined by your doctor based on the type and intensity of cancer treatment.

Side effects may include fatigue, headache, constipation, diarrhea, or reactions at the injection site. In rare cases, severe allergic reactions or changes in liver function may occur. Any unusual symptoms should be reported to the medical team immediately.

Fosaprepitant is an effective medication for preventing severe nausea associated with chemotherapy, helping to improve the quality of life for cancer patients. Follow your doctor's instructions and report any adverse reactions to ensure the safety of the treatment.

General data about IVEMEND 150mg 1mg / ml

Substance: fosaprepitant

Date of last drug list: 01-07-2013

Commercial code: W57337002

Concentration: 1mg / ml

Pharmaceutical form: powder infusion solution

Quantity: 10

Product type: original

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.